Dr. Andrew Swift BMedSci MBChB MRCP FRCR PhD
Wellcome Trust Clinical Career Development Fellow
Department of Infection, Immunity & Cardiovascular Disease
University of Sheffield
C Floor, Royal Hallamshire Hospital
Tel: +44 (0) 114 215 9143
Fax: +44 (0) 114 271 1714
I studied medicine at Sheffield University, graduating in 2003. Following basic medical training I undertook specialist radiology training on the Hull Radiology training scheme.
I joined the University of Sheffield in 2010 as a NIHR Cardiovascular Clinical Fellow and I was awarded a NIHR Biomedical Research Fellowship to complete my PhD entitled “Developing the Role of Magnetic Resonance Imaging in Pulmonary Hypertension”. I am interested in the use of computer science in medicine to improve diagnosis and prognostication, I was employed by INSIGNEO for 5 years as a research fellow and am now a Wellcome Trust Clinical Career Development Fellow.
My research interests include the clinical application of novel imaging techniques and analysis approaches in patients with cardiac and pulmonary disease.
- Undergraduate and post graduate research skills training.
- Radiology teaching for registrars.
- Cluster leader for BMedSci course.
- Member of the Royal College of Physicians 2006.
- Fellow of the Royal College of Radiologists 2010.
- Member of the Pulmonary Vascular Research Institute (PVRI) 2013.
- Associate editor Clinical Radiology 2015.
- PVRI imaging workgroup co-founder with Professor David Kiely 2015.
- Collaborator - Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research 2015.
- Machine learning to improve disease assessment in cardiac and pulmonary disease.
- Developing MRI as diagnostic and prognostic tool - DITCH.
- Lung subtraction Iodine mapping in patients with suspected chronic emboli - INSITGATE.
- Repeatability of magnetic resonance imaging cardiopulmonary metrics in pulmonary arterial hypertension - Implications for trial design.
- Understanding the phenotype of genetic variants using magnetic resonance imaging and computed tomography - COHORT study.
- Risk stratification of patients with cardiac and pulmonary disorders.
For key publications see below. For a full list of publications click here.
Key words: Swift A Sheffield OR Swift A Hull
- The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension. European Respiratory Journal, 52(3). View this article in WRRO
- Identifying At-Risk Patients with Combined Pre- and Postcapillary Pulmonary Hypertension Using Interventricular Septal Angle at Cardiac MRI. Radiology, 289(1), 180120-180120. View this article in WRRO
- Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility. Frontiers in Cardiovascular Medicine, 5. View this article in WRRO
- CT derived left atrial size identifies left heart disease in suspected pulmonary hypertension: Derivation and validation of predictive thresholds. International Journal of Cardiology, 260, 172-177. View this article in WRRO
- Phenotypic Characterisation of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically with Pulmonary Arterial Hypertension.. Circulation, 136(21), 2022-2033. View this article in WRRO
- Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine, 196(2). View this article in WRRO
- Longitudinal and Transverse Right Ventricular Function in Pulmonary Hypertension: Cardiovascular Magnetic Resonance Imaging Study from the ASPIRE Registry. Pulmonary Circulation, 5(3), 557-564.
- Right Ventricular Sex Differences in Patients with Idiopathic Pulmonary Arterial Hypertension Characterised by Magnetic Resonance Imaging: Pair-Matched Case Controlled Study. PLOS ONE, 10(5), e0127415-e0127415. View this article in WRRO
- LGE Patterns in Pulmonary Hypertension Do Not Impact Overall Mortality. JACC: Cardiovascular Imaging, 7(12), 1209-1217.
- Dynamic contrast-enhanced magnetic resonance imaging in patients with pulmonary arterial hypertension.. Pulm Circ, 4(1), 61-70. View this article in WRRO
- Prognostic value of cardiovascular magnetic resonance imaging measurements corrected for age and sex in idiopathic pulmonary arterial hypertension.. Circ Cardiovasc Imaging, 7(1), 100-106.
- Noninvasive estimation of pa pressure, flow, and resistance with CMR imaging: Derivation and prospective validation study from the aspire registry. JACC: Cardiovascular Imaging, 6(10), 1036-1047.
- Pulmonary artery relative area change detects mild elevations in pulmonary vascular resistance and predicts adverse outcome in pulmonary hypertension.. Invest Radiol, 47(10), 571-577.